NASDAQ:IMCR
Immunocore Holdings plc Stock News
$60.23
+0.770 (+1.29%)
At Close: May 03, 2024
Immunocore to present at upcoming investor conferences
04:00pm, Thursday, 04'th Apr 2024
Immunocore to present at upcoming investor conferences (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md.
Immunocore to present at upcoming investor conferences
07:00am, Friday, 01'st Mar 2024
Immunocore to present at upcoming investor conferences (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md.
Immunocore to report fourth quarter and full year 2023 financial results and host call on February 28, 2024
07:00am, Wednesday, 21'st Feb 2024
Immunocore to report fourth quarter and full year 2023 financial results and host call on February 28, 2024 (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md.
5 Biotech Stocks to Consider for Your Portfolio in 2024
10:00am, Tuesday, 13'th Feb 2024
New drug approvals and pipeline progress are likely to help maintain momentum for the Zacks Biomedical and Genetics industry. A strong portfolio and solid pipeline progress position SRPT, EXEL, IMCR,
Immunocore Holdings PLC Sponsored ADR (IMCR) Moves 6.9% Higher: Will This Strength Last?
06:20am, Thursday, 01'st Feb 2024
Immunocore Holdings PLC Sponsored ADR (IMCR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue movin
New Strong Buy Stocks for January 10th
07:31am, Wednesday, 10'th Jan 2024
PCRFY, IMCR, CPRX, AMPX and ENS have been added to the Zacks Rank #1 (Strong Buy) List on January 10, 2024.
Immunocore to present at the 42nd Annual J.P. Morgan Healthcare Conference
07:00am, Wednesday, 03'rd Jan 2024
Immunocore to present at the 42 nd Annual J.P. Morgan Healthcare Conference
Immunocore Holdings PLC Sponsored ADR (IMCR) Upgraded to Buy: Here's What You Should Know
01:32pm, Monday, 18'th Dec 2023
Immunocore Holdings PLC Sponsored ADR (IMCR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the ne
Can Immunocore Holdings PLC Sponsored ADR (IMCR) Climb 75.55% to Reach the Level Wall Street Analysts Expect?
11:17am, Monday, 27'th Nov 2023
The consensus price target hints at a 75.6% upside potential for Immunocore Holdings PLC Sponsored ADR (IMCR). While empirical research shows that this sought-after metric is hardly effective, an upwa
Wall Street Analysts See a 66.42% Upside in Immunocore Holdings PLC Sponsored ADR (IMCR): Can the Stock Really Move This High?
11:16am, Friday, 10'th Nov 2023
The mean of analysts' price targets for Immunocore Holdings PLC Sponsored ADR (IMCR) points to a 66.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, s
Immunocore to present at upcoming investor conferences
04:30pm, Monday, 30'th Oct 2023
Immunocore to present at upcoming investor conferences (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md.
Immunocore to present at upcoming investor conferences
05:00pm, Monday, 11'th Sep 2023
Immunocore to present at upcoming investor conferences (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md.
Institutions are Buying These 3 Stocks and Analysts Agree
10:05am, Thursday, 07'th Sep 2023
A significant but less-spoken or popular metric that investors should keep a watchful eye on is the institutional flow of capital into individual stocks. Institutional buying, often called "smart mone
Immunocore to present at upcoming investor conferences
04:00pm, Friday, 01'st Sep 2023
Immunocore to present at upcoming investor conferences (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md.
Immunocore: KIMMTRAK Adoption Continues At Rapid Pace, Expanding To New Markets, Reiterate Buy
12:28pm, Sunday, 27'th Aug 2023
Immunocore's KIMMTRAK segment continues to see rapid adoption, expanding into additional European markets and Israel. The launch curve of KIMMTRAK has been impressive, with TTM revenues up 494% from Q
